Cartesian Therapeutics Inc (NAS:RNAC)
$ 8.43 -0.26 (-2.99%) Market Cap: 255.05 Mil Enterprise Value: 171.30 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 28/100

Cartesian Therapeutics Inc (RNAC) Transcripts

  • 1